NEW YORK - Pfizer-BioNTech on Friday requested to expand the emergency use of its COVID-19 vaccine in the United States for older children ages 12 to 15. The request asks the U.S. Food and Drug ...

HOUSTON, Texas (KTRK) -- After months of waiting, Bellaire High School sophomore Nina Wallach made her first appointment for a COVID-19 vaccine Monday. "I got a notification on my phone after English ...

The US Food and Drug Administration (FDA) on Monday authorized Pfizer and BioNTech’s COVID-19 vaccine for use in adolescents 12 to 15 years of age. "The FDA's expansion of the emergency use ...

Pfizer/BioNTech has officially filed with the Food and Drug Administration seeking to expand their emergency use authorization for their COVID-19 vaccine in children aged 12 to 15 years old. When the ...

WASHINGTON — The U.S. Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine for young adults age 12 and older by next week, according to a federal official and a person ...

WASHINGTON — Clinical trial results of Pfizer/BioNTech's COVID-19 vaccine showed its efficacy is 100 percent and it is well tolerated in youths ages 12 to 15, the manufacturer said on Wednesday.

U.S. regulators on Monday expanded the use of Pfizer's COVID-19 vaccine to children as young as 12, offering a way to protect the nation's adolescents before they head back to school in the fall and ...